Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

BabyScreen+ newborn screening

Gene: SLC2A1

Green List (high evidence)

SLC2A1 (solute carrier family 2 member 1, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000117394
EnsemblGeneIds (GRCh37): ENSG00000117394
OMIM: 138140, ClinGen, DECIPHER
SLC2A1 is in 33 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Few bi-allelic cases reported. Presentation is more severe, uncertain if outcome would be comparable but no reason not to try treatment. Likely to be symptomatic in infancy anyway.
Created: 14 Dec 2022, 4:15 p.m. | Last Modified: 14 Dec 2022, 4:15 p.m.
Panel Version: 0.1420

Mode of inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal

Phenotypes
GLUT1 deficiency syndrome 1, infantile onset, severe, MIM#606777; Dystonia 9, MIM#601042; GLUT1 deficiency syndrome 2, childhood onset, MIM#612126

Seb Lunke (Victorian Clinical Genetics Services)

Green List (high evidence)

Comment on mode of inheritance: Review if bi-allelic form is indeed relevant for NBS
Created: 12 Dec 2022, 3:35 p.m. | Last Modified: 12 Dec 2022, 3:35 p.m.
Panel Version: 0.1325
Established gene-disease association.

Childhood onset, neurological disorder. Variable severity, with null variants generally more severe.

Treatment: ketogenic diet and carnitine, avoid barbiturates, methyxanthine(caffeine), valproic acid

Non-genetic confirmatory test: comparison of blood glucose concentration with CSF glucose concentration obtained after 4 hr fast
Created: 12 Dec 2022, 3:34 p.m. | Last Modified: 12 Dec 2022, 3:34 p.m.
Panel Version: 0.1323

Mode of inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal

Phenotypes
GLUT1 deficiency syndrome 1, infantile onset, severe, MIM#606777; Dystonia 9, MIM#601042; GLUT1 deficiency syndrome 2, childhood onset, MIM#612126

History Filter Activity

14 Dec 2022, Gel status: 3

Added Tag, Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag treatable tag was added to gene: SLC2A1. Tag neurological tag was added to gene: SLC2A1.

12 Dec 2022, Gel status: 3

Entity classified by Genomics England curator

Seb Lunke (Victorian Clinical Genetics Services)

Gene: slc2a1 has been classified as Green List (High Evidence).

12 Dec 2022, Gel status: 3

Set mode of inheritance

Seb Lunke (Victorian Clinical Genetics Services)

Mode of inheritance for gene: SLC2A1 was changed from BOTH monoallelic and biallelic, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

12 Dec 2022, Gel status: 3

Set mode of inheritance

Seb Lunke (Victorian Clinical Genetics Services)

Mode of inheritance for gene: SLC2A1 was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

19 Sep 2022, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

gene: SLC2A1 was added gene: SLC2A1 was added to gNBS. Sources: BeginNGS,BabySeq Category A gene,Expert Review Green Mode of inheritance for gene: SLC2A1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: SLC2A1 were set to GLUT1 deficiency syndrome 2, childhood onset, 612126; {Epilepsy, idiopathic generalized, susceptibility to, 12}, MIM#614847; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777